ArticleParasitology research2026
Imported mixed malaria caused by Plasmodium falciparum and Plasmodium ovalecurtisi: An Italian case report.
Article in Parasitology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malaria remains a major global health threat, particularly in endemic regions of sub-Saharan Africa. In 2024 alone, an estimated 282 million cases were reported worldwide, with approximately 610,000 associated deaths. Beyond the high disease burden, mixed-species Plasmodium infections represent an additional clinical challenge, as they are frequently underdiagnosed and may significantly complicate both diagnostic accuracy and therapeutic management even in non-endemic countries. We report the case of a 67-year-old man from Guinea who presented to the Emergency Department with high-grade fever and asthenia shortly after returning to Italy; initial microbiological investigations were negative, despite markedly elevated inflammatory markers were diagnosed. The patient reported a previous untreated malaria episode approximately six months earlier, raising suspicion of a novel Plasmodium infection. A comprehensive malaria diagnostic workflow was promptly initiated, integrating rapid immunoenzymatic testing (IE), microscopy, and molecular assays. The IE test suggested Plasmodium falciparum or a mixed infection as result, while loop-mediated isothermal amplification (LAMP-PCR) confirmed the presence of Plasmodium spp DNA. Microscopic examination of stained blood smears revealed typical P. falciparum ring forms and suspected P. ovale trophozoites; so, species-specific real-time PCR confirmed a mixed infection with P. falciparum and P. ovale, supporting prompt antimalarial treatment. Final molecular confirmation was achieved by Sanger sequencing, which identified the Plasmodium ovalecurtisi as co-aetiological agent of disease. The rapid and integrated diagnostic approach enabled timely initiation of appropriate antimalarial therapy with artemether-lumefantrine and primaquine, leading to complete clinical recovery and gene sequencing allowed a correct species confirmation and epidemiological characterization. This case highlights the importance of combining microscopic analysis with advanced molecular diagnosis for an accurate identification of mixed Plasmodium infections even in country and contributes novel epidemiological data through molecular characterization of P. ovalecurtisi in an imported case.
Indexed as
Identifiers
42911424What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.